Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma

por Younes, Anas, Salles, Gilles, Martinelli, Giovanni, Bociek, Robert Gregory, Barrigon, Dolores Caballero, Barca, Eva González, Turgut, Mehmet, Gerecitano, John, Kong, Oliver, Pisal, Chaitali Babanrao, Tavorath, Ranjana, Kim, Won Seog
Publicado 2017

PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

por Duell, Johannes, Abrisqueta, Pau, Dreyling, Martin, Gaidano, Gianluca, Barca, Eva González, Jurczak, Wojciech, Liberati, Anna Marina, Maddocks, Kami, Menne, Tobias, Nagy, Zsolt, Tournilhac, Olivier, Bakuli, Abhishek, Amin, Aasim, Gurbanov, Konstantin, Salles, Gilles
Publicado 2023